In addition, when patients were subclassified with respect to IDH mutation status, IDH wildtype was found to be more associated with an increased pattern of BDKRB2 expression in both datasets, except for the subgroup of WHO grade II in CGGA dataset, which also exhibited an apparent trend ( Figure 1B , 1F ).
← all excerpts
BDKRB2 is a novel EMT-related biomarker and predicts poor survival in glioma.
1
—
—